Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinyun Chen

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Cell Metabolism|September 7, 2022
ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytesZhen Lu, Noreen McBrearty, Jinyun Chen, et al.
Nature Communications|November 5, 2022
Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancerZhen Lu, Jinyun Chen, Pengfei Yu, et al.
Cell Reports. Medicine|September 30, 2025
Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen densityAlex Quan, Mingyu Huo, Dan Li, et al.
Nature Communications|March 20, 2021
Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathwayKevin Alicea-Torres, Emilio Sanseviero, Jun Gui, et al.
Cancer Discovery|July 11, 2013
DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transitionNanyue Chen, Seetharaman Balasenthil, Jacquelyn Reuther, et al.
Cancer Cell|March 16, 2010
An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cellsQing Sheng, Xinggang Liu, Eleanor Fleming, et al.
Molecular Cancer Research : MCR|November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer CellsNoreen McBrearty, Christina Cho, Jinyun Chen, et al.
Structure (London, England : 1993)|January 31, 2017
Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform SelectivityXiaoling Xie, Daniel Baird, Kimberly Bowen, et al.
Chemistry & Biology|December 30, 2014
The novolactone natural product disrupts the allosteric regulation of Hsp70A Quamrul Hassan, Christina A Kirby, Wenlai Zhou, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 InhibitorsQian Zhao, James R Manning, James Sutton, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Cell Metabolism|September 7, 2022
ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytesZhen Lu, Noreen McBrearty, Jinyun Chen, et al.
Nature Communications|November 5, 2022
Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancerZhen Lu, Jinyun Chen, Pengfei Yu, et al.
Cell Reports. Medicine|September 30, 2025
Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen densityAlex Quan, Mingyu Huo, Dan Li, et al.
Nature Communications|March 20, 2021
Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathwayKevin Alicea-Torres, Emilio Sanseviero, Jun Gui, et al.
Cancer Discovery|July 11, 2013
DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transitionNanyue Chen, Seetharaman Balasenthil, Jacquelyn Reuther, et al.
Cancer Cell|March 16, 2010
An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cellsQing Sheng, Xinggang Liu, Eleanor Fleming, et al.
Molecular Cancer Research : MCR|November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer CellsNoreen McBrearty, Christina Cho, Jinyun Chen, et al.
Structure (London, England : 1993)|January 31, 2017
Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform SelectivityXiaoling Xie, Daniel Baird, Kimberly Bowen, et al.
Chemistry & Biology|December 30, 2014
The novolactone natural product disrupts the allosteric regulation of Hsp70A Quamrul Hassan, Christina A Kirby, Wenlai Zhou, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 InhibitorsQian Zhao, James R Manning, James Sutton, et al.
Pageof 14